JAMP Guanfacine XR 1 mg tablets: One lot recalled as some bottles may also contain higher strength tablets
See all recalls from JAMP →Recalled Product
JAMP Guanfacine XR 1 mg tablets
✅ What Should You Do?
- ⚠️ Stop using this product until you have checked the recall details below.
- Check your or your child's pill bottle of JAMP Guanfacine XR 1 mg tablets to ensure it contains only 1 mg white, round tablets.
- 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
- 📋 Report a product safety incident to Health Canada
Looking for a safe alternative?
Search Amazon Canada for JAMP Guanfacine XR 1 →
Hazard / Issue
Product safety
Issued by
Communications and Public Affairs Branch
⚠️ What You Should Do
Check your or your child's pill bottle of JAMP Guanfacine XR 1 mg tablets to ensure it contains only 1 mg white, round tablets. If it contains any JAMP Guanfacine XR 4 mg green, oval tablets, or if you are unsure, return it to your pharmacy. Your pharmacist will check it and provide you with a replacement if needed.Contact a health care professional immediately if you or your child are experiencing signs and symptoms of overdose.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals:Health care professionals, such as pharmacists, should check bottles of Guanfacine XR 1 mg tablets before dispensing and report any unusual bottles or other issue to the company and to Health Canada.
⚖️ Were You Affected?
If you were injured or suffered a loss due to this recalled product, you may have legal options.
Search for Class Action Lawyers →Consumer Recalls Canada is not a law firm and does not provide legal advice. We may receive a referral fee if you inquire. We are not affiliated with any law firm or legal service.
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime